Executive read
Facilities, beds, daily patients, and levels of care are different denominators. The public evidence supports a measurement blueprint, but not yet the company-audit depth of Dental or Med Spa.
Four lenses translate the public evidence into the questions a category marketer needs to answer: how demand is created, where conversion happens, where measurement breaks, and what to change.
Search and referral meet a safety decision
Consumer search, physician or payer referral, and helplines begin a journey that must first determine clinical fit and safety.
Admission is not a generic booking
Assessment, benefit verification, level-of-care placement, and bed or program capacity precede treatment start.
One network contains different care settings
Acute, residential, outpatient, and treatment-center programs cannot share one lead-to-revenue denominator.
Optimize to appropriate treatment start
Join source, assessment, eligibility, placement, admission, attendance, step-down, and payer context without activating sensitive clinical data.
Directional conclusions from 0 completed public-source reviews across 4 operators. The remaining company deep dives can change the segment read.
Category evidence
Four findings worth carrying into the operating model
This page publishes a terminology, denominator, and measurement blueprint from current primary sources. It does not pretend to have Dental-level company-audit depth. Counts below keep their original unit and date; no parent/child brands, stores, clinics, laboratories, beds, or partner sites are silently added together.
This is a foundation, not a benchmark
No full company audit is complete. Current first-party filings define the care settings and denominators that future audits must preserve.
Facilities, beds, and daily patients cannot be summed
Acadia reports 279 facilities, about 12,600 beds, and more than 84,000 patients daily. Each answers a different operating question.
One network contains multiple funnels
Acute, specialty, comprehensive treatment, residential, outpatient, PHP, and IOP settings have different admission, occupancy, attendance, and length-of-stay economics.
Appropriate admission matters more than inquiry volume
Safety and clinical assessment, insurance, level-of-care placement, and capacity determine whether an inquiry should become treatment.
Measurement path
The useful outcome sits beyond the lead
Clinical appropriateness and safety precede commercial conversion. Bed or program capacity, care setting, length of stay, and sensitive data governance make a conventional clinic lead funnel unsafe.
- 01 search, referral, or helpline
- 02 safety and clinical assessment
- 03 insurance verification
- 04 level-of-care placement
- 05 admission or treatment start
- 06 attendance, length of stay, or step-down
- 07 discharge and follow-up
facility/program × level of care × payer × capacity × day
appropriate, completed treatment start with protected outcomes
- assessment completion
- time-to-admit
- admission rate
- occupancy by level of care
- attendance and step-down
Creative evidence
The category becomes legible when the real work is visible
These attributed first-party examples show how operators frame need, trust, access, and outcomes. They are editorial evidence—not a performance ranking.
A real therapy setting keeps the message clinical and non-stigmatizing
The image supports an assessment-and-treatment journey without using crisis imagery or implying that one outcome applies to every patient.
The network presents access before it presents corporate scale
The human-centered frame is appropriate for a category where the first useful marketing outcome is an appropriate assessment and treatment start, not a raw inquiry.
Recovery is framed through possibility, not vulnerability
The outcome-led scene avoids stigmatizing treatment imagery while still giving the audience a clear reason to seek an assessment.
3 of 3 examples shown
AI adoption
Nine workflows—what AI changes, and what it still cannot fix
Behavioral-health and addiction-treatment marketing needs a closed loop from inquiry to clinically appropriate admission without exposing highly sensitive identity or treatment data. The strongest current evidence is in call classification, admissions routing, and outcome feedback—not content generation.
No private operator audit exists for this segment. Eleanor Health, Guardian Recovery, and S2L Recovery are vendor-hosted named cases; their results are self-reported, not independent or category-wide. The Suzy chatbot is a small peer-reviewed pilot, not a marketing deployment.
Creative production
Rare Maturity basis · Cross-industry proxyAd platforms can generate creative variants, but no audited behavioral-health operator evidence shows a governed production workflow.
Still manual / non-AITeams still control treatment claims, crisis language, representation, consented imagery, geography, program availability, and approval.
Meta documents generative creative capability across advertisers; it does not publish behavioral-health operator adoption evidence.
Sensitive-health policy, stigma, crisis risk, treatment claims, and rapidly changing bed or program availability constrain automation.
Message and copy generation
Rare Maturity basis · Verified industry evidenceA 2026 formative study tested a substance-use-disorder chatbot for reminders, referrals, and craving support—not acquisition copy or autonomous clinical advice.
Still manual / non-AICampaign claims, crisis response, clinical suitability, consent, tone, local resources, and patient-specific guidance require experts.
The May 20, 2026 JMIR study used small formative and usability samples. It supports feasibility questions, not operator adoption or marketing outcomes.
A research prototype cannot safely generalize to crisis, treatment, payer, or promotional messaging without clinical governance.
Paid-media optimization
Emerging Maturity basis · Operator exampleEleanor Health's vendor case sends verified booking outcomes to Google and reduced campaign fragmentation around a downstream conversion signal.
Still manual / non-AITeams still set market, program, eligibility, exclusions, capacity, budget, and the boundary between permissible optimization and sensitive-health data.
Liine's July 10, 2026 case describes four campaigns across 20 markets over 90 days and reports directional booking-efficiency gains. Results are vendor-reported and not independently causal.
A booking is still upstream of eligibility, assessment, admission, retained care, and revenue, and feedback fields may be highly sensitive.
SEO and GEO
Rare Maturity basis · Improvado hypothesisNo private audit or named operator evidence was found for a governed behavioral-health GEO workflow.
Still manual / non-AIProgram, clinician, accreditation, payer, location, availability, crisis, and medically reviewed content facts require continuous ownership.
Google says established Search fundamentals apply to AI features. This is search-engine guidance, not behavioral-health adoption proof.
High-stakes answers can be harmful when program availability, eligibility, or crisis resources are stale or geographically wrong.
UTM, attribution, and data QA
Emerging Maturity basis · Operator exampleEleanor Health's named case deduplicates calls, forms, and bookings, matches outcomes to Athena, and sends booking feedback to Google.
Still manual / non-AISource taxonomy, patient identity, qualification, consent, assessment, admission, payer, revenue, and permissible data activation still need governance.
Liine reports high EHR match quality and a reporting workflow shortened from 90 minutes to five. The case publishes no record denominator or independent validation.
Identity resolution and marketing activation can expose treatment-related data unless purpose, fields, contracts, and access are tightly limited.
Call analysis
Emerging Maturity basis · Operator exampleEleanor Health's vendor case uses AI to classify calls, opportunities, and bookings across 20 markets.
Still manual / non-AIClinical urgency, crisis assessment, eligibility, disputed dispositions, staff coaching, and admission reconciliation remain human-owned.
The named July 2026 case documents production use. Performance claims come from Liine and are not an independent clinical or causal evaluation.
Misclassification can affect both patient access and media optimization, while transcripts may contain especially sensitive information.
Lead routing and CRM
Emerging Maturity basis · Operator exampleGuardian Recovery's vendor case describes an AI voice agent on the admissions line that writes call outcomes and verification-of-benefits data to CRM.
Still manual / non-AIClinical appropriateness, crisis response, payer exceptions, consent, complex VOB, placement, and admission decisions remain human.
DIAL3D reports 17 additional admissions and full after-hours answer coverage. Its cofounder is also Guardian's CSO, so the case is closely affiliated and self-reported.
Fast routing can create harm if urgency, program fit, payer data, consent, and human escalation are wrong or incomplete.
Scheduling and patient engagement
Emerging Maturity basis · Operator exampleProduction vendor cases show after-hours admissions engagement, while peer-reviewed research explores reminders and resource referrals.
Still manual / non-AIClinical triage, crisis care, eligibility, consent, placement, transportation, treatment planning, and complex follow-up remain staff-owned.
The 2025 deployment is documented only by the closely affiliated vendor/customer case; workload and admission results are self-reported.
A responsive agent cannot determine safe level of care or replace crisis and clinical judgment.
Compliance and privacy
Rare Maturity basis · Verified industry evidenceAI can flag sensitive fields, redact transcripts, and test routing rules, but no audited operator governance implementation was found.
Still manual / non-AIHIPAA, 42 CFR Part 2, consent, redisclosure, BAAs, minimum-necessary use, ad-policy review, and incident ownership remain accountable decisions.
Current HHS guidance explicitly addresses substance-use-disorder records. It defines obligations; it does not certify AI compliance.
Treatment identity and transcript content can be highly sensitive, and a technically valid join may still be impermissible to activate.
Operator map
Where behavioral health operators sit
This foundation category does not yet have a defensible scored operator point. The wider cohort remains visible for context; no category position is implied.
Where public demand intensity meets marketing-operations centralization
Directional scores synthesize dated public ad-library, website, tag-layer, and operating-model evidence. They are not spend, revenue, or vendor-performance scores.
- Aspen Dental: paid demand 70 out of 100; marketing operations centralization 88 out of 100.
- Heartland Dental: paid demand 45 out of 100; marketing operations centralization 22 out of 100.
- PDS Health: paid demand 72 out of 100; marketing operations centralization 92 out of 100.
- SALT Dental Partners: paid demand 22 out of 100; marketing operations centralization 15 out of 100.
- Smile Brands: paid demand 68 out of 100; marketing operations centralization 20 out of 100.
- Smile Doctors: paid demand 72 out of 100; marketing operations centralization 62 out of 100.
- Sonrava Health: paid demand 68 out of 100; marketing operations centralization 34 out of 100.
- Forefront Dermatology: paid demand 26 out of 100; marketing operations centralization 86 out of 100.
- QualDerm Partners: paid demand 30 out of 100; marketing operations centralization 58 out of 100.
- US Fertility: paid demand 55 out of 100; marketing operations centralization 16 out of 100.
- LaserAway: paid demand 78 out of 100; marketing operations centralization 70 out of 100.
- Milan Laser: paid demand 90 out of 100; marketing operations centralization 74 out of 100.
- SEV Laser: paid demand 82 out of 100; marketing operations centralization 72 out of 100.
- 4Ever Young: paid demand 76 out of 100; marketing operations centralization 55 out of 100.
- SkinSpirit: paid demand 68 out of 100; marketing operations centralization 84 out of 100.
- VIO Med Spa: paid demand 72 out of 100; marketing operations centralization 55 out of 100.
- OVME: paid demand 63 out of 100; marketing operations centralization 80 out of 100.
- Ever/Body: paid demand 55 out of 100; marketing operations centralization 78 out of 100.
- Beltone: paid demand 30 out of 100; marketing operations centralization 12 out of 100.
- HearingLife: paid demand 30 out of 100; marketing operations centralization 84 out of 100.
- Miracle-Ear: paid demand 40 out of 100; marketing operations centralization 45 out of 100.
- The Joint: paid demand 84 out of 100; marketing operations centralization 52 out of 100.
- ATI Physical Therapy: paid demand 30 out of 100; marketing operations centralization 70 out of 100.
- NovaCare: paid demand 10 out of 100; marketing operations centralization 74 out of 100.
- Select Physical Therapy: paid demand 12 out of 100; marketing operations centralization 66 out of 100.
- U.S. Physical Therapy: paid demand 10 out of 100; marketing operations centralization 12 out of 100.
- Upstream Rehabilitation: paid demand 14 out of 100; marketing operations centralization 38 out of 100.
- American Family Care: paid demand 62 out of 100; marketing operations centralization 15 out of 100.
- CityMD: paid demand 40 out of 100; marketing operations centralization 80 out of 100.
- Concentra: paid demand 6 out of 100; marketing operations centralization 72 out of 100.
- USA Vein Clinics: paid demand 64 out of 100; marketing operations centralization 84 out of 100.
- Banfield: paid demand 52 out of 100; marketing operations centralization 76 out of 100.
- Thrive Pet Healthcare: paid demand 58 out of 100; marketing operations centralization 30 out of 100.
- VCA Animal Hospitals: paid demand 50 out of 100; marketing operations centralization 72 out of 100.
- VetCor: paid demand 18 out of 100; marketing operations centralization 38 out of 100.
- MyEyeDr: paid demand 85 out of 100; marketing operations centralization 85 out of 100.
- National Vision: paid demand 45 out of 100; marketing operations centralization 68 out of 100.
Footprints
Largest known operator footprints
Location counts come from the dated research registry and first-party public directories. They are shown to explain operating scale, not to rank quality or performance.
Implications
The measurement design follows the operating model
Model location explicitly
Media, calls, forms, appointments, and revenue need one durable facility identifier.
Separate collection from activation
Privacy-safe collection does not by itself create a governed reporting or activation layer.
Preserve local context
National rollups stay useful only when teams can drill into brand, market, service, and location.
This section describes data-design implications from the research. It is not a claim that every operator has the same stack, privacy obligations, or level of centralization.
Method
A dated public-source edition
The segment inherits the parent report method: location directories, sitemaps, booking paths, public web tags, ad transparency libraries, ownership announcements, and public operating-model evidence.
Private CRM history, sales calls, contacts, customer data, internal scoring, and recommendations are excluded. Technology detection means a signal was visible on a reviewed surface; it does not prove enterprise-wide deployment.
- No complete company audit exists in the current private corpus.
- Facility, bed, program, and daily-patient counts are deliberately not combined.
- Sensitive patient and outcome data must remain outside advertising activation systems.
4 primary sources in this category synthesis
- Acadia investor releases Primary facility, bed, geography, and daily-patient denominators. ↗
- Pinnacle 2023 report Historical first-party network context; not treated as a current location total. ↗
- BayMark First-party treatment-network and daily-patient context; accessed August 4, 2026. ↗
- Discovery locations First-party facility and program discovery; accessed August 4, 2026. ↗